A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
Clinical trial NCT06663436 · COMPLETED
Trial details
- NCT number
- NCT06663436
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2025-10-21
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.